Candriam Equities L Oncology I GBP Cap
Asset allocation %
Morningstar style box TM
Equity style
SizeLarge
Mid
Small
Value
Blend
Growth
Style
Size
| Share class size (mil) | 8 GBP (17/11/2026) |
| Fund size (mil) | 1,281 GBP (17/11/2026) |
Top 10 holdings
| Assets in top 10 holdings % | 38.00 |
| Total number of equity holdings | 68 |
| Total number of bond holdings | 0 |
| Holdings 30/04/2026 | % of assets |
|---|---|
| Eli Lilly and Co | 7.06 |
| AstraZeneca PLC | 4.87 |
| Novartis AG Registered Shares | 4.01 |
| Thermo Fisher Scientific Inc | 3.76 |
| Merck & Co Inc | 3.65 |
| Pfizer Inc | 3.16 |
| AbbVie Inc | 3.05 |
| McKesson Corp | 3.01 |
| Gilead Sciences Inc | 2.87 |
| Bristol-Myers Squibb Co | 2.56 |